# Contents
Allianz Biotechnologie
Fund Assets in %
|  |  |  |  |
| --- | --- | --- | --- |
|  |  |  |  |
|  |  |  |  |
|  |  |  |  |
|  |  |  | 3.1  3.1 |

100
80
60
40
20
0
96.9 96.9
USD	Cash reserves, other assets
| Development of net assets and | unit value in a 3-year comparison |  |
| --- | --- | --- |
|  |  | 30/06/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 |
| Net assets in EUR m - Unit class A (EUR) | WKN: 848 186/ISIN: DE0008481862 | 280.9 | 267.9 | 296.0 | 201.8 |
| - Unit class R (EUR) | WKN: A2A MPU/ISIN: DE000A2AMPU5 | 192,513.60  1) | 419,495.00  1) | 77,027.55  1) | 1,680,.86  1) |
| Unit value in EUR - Unit class A (EUR) | WKN: 848 186/ISIN: DE0008481862 | 219.99 | 203.12 | 174.90 | 131.66 |
| - Unit class R (EUR) | WKN: A2A MPU/ISIN: DE000A2AMPU5 | 160.27 | 147.35 | 125.76 | 93.85 |

1) 
Not shown in EUR million due to fund’s low volume.
| Asset overview at 30/06/2021 |  |
| --- | --- |
| Breakdown by asset category – country | Market value in EUR | % of net assets  *) |  | Breakdown by asset category – currency | Market value in EUR | % of net assets  *) |
| I. Assets |  |  |  | I. Assets |  |  |
| 1. Equities | 272,529,160.46 | 96.93 |  | 1. Equities | 272,529,160.46 | 96.93 |
| Germany | 5,583,402.46 | 1.99 |  | USD | 272,529,160.46 | 96.93 |
| The Netherlands | 2,750,038.28 | 0.98 |  | 2. Other securities | 1,356.33 | 0.00 |
| Ireland | 15,161,312.64 | 5.39 |  | USD | 1,356.33 | 0.00 |
| Denmark | 1,545,168.40 | 0.55 |  | 3. Derivatives | 682,325.63 | 0.24 |
| Switzerland | 2,757,894.96 | 0.98 |  | 4. Bank deposits, money market | 7,553,678.10 | 2.69 |
| UK | 14,321,544.54 | 5.09 |  | instruments, money market funds and |  |  |
| USA | 223,640,465.45 | 79.54 |  | money market-related funds |  |  |

| Cayman Islands | 4,122,414.86 | 1.47 |
| --- | --- | --- |
| British Virgin Islands | 2,646,918.87 | 0.94 |
| 2. Other securities | 1,356.33 | 0.00 |
| USA | 1,356.33 | 0.00 |
| 3. Derivatives | 682,325.63 | 0.24 |
| 4. Bank deposits, money market instruments, money market funds and | 7,553,678.10 | 2.69 |
| money market-related funds |  |  |
| 5. Other assets | 5,474,316.98 | 1.95 |
| II. Liabilities | -5,099,244.16 | -1.81 |
| III. Fund assets | 281,141,593.34 | 100.00 |

| 5. Other assets | 5,474,316.98 | 1.95 |
| --- | --- | --- |
| II. Liabilities | -5,099,244.16 | -1.81 |
| III. Fund assets | 281,141,593.34 | 100.00 |

*) 
Minor rounding differences may be the result of percentage rounding during the calculation.
Investment portfolio at 30/06/2021
ISIN	Securities	Market	Shares/	Balance  Purchases  Redemptions	Price	Market value	% of net
Units/	30/06/2021	in EUR	assets
Currency	in the period under review
| Exchange-traded | securities |  |  |  |  |  | 272,529,160.46 | 96.93 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equities |  |  |  |  |  |  | 272,529,160.46 | 96.93 |
| Biotechnology |  |  |  |  |  |  | 208,721,853.76 | 74.23 |
| US00434H1086 | Acceleron Pharma Inc. Reg.Shares | SHS | 8,740 | 0 | 0 USD | 124.490 | 914,283.10 | 0.33 |
| CH0499880968 | ADC Therapeutics S.A. Namens-Aktien Cl.C | SHS | 20,515 | 0 | 28,775 USD | 24.200 | 417,178.27 | 0.15 |
| US00847X1046 | Agios Pharmaceuticals Inc. Reg.Shares | SHS | 36,340 | 0 | 7,295 USD | 53.530 | 1,634,620.56 | 0.58 |
| US0144421072 | Alector Inc. Reg.Shares | SHS | 500 | 0 | 0 USD | 20.620 | 8,663.50 | 0.00 |
| US0153511094 | Alexion Pharmaceuticals Inc. Reg.Shares | SHS | 43,000 | 0 | 13,975 USD | 184.300 | 6,659,300.03 | 2.37 |
| US01671P1003 | Allakos Inc. Reg.Shares | SHS | 30,485 | 0 | 0 USD | 88.320 | 2,262,455.53 | 0.80 |
| US0197701065 | Allogene Therapeutics Inc. Reg.Shares | SHS | 15,965 | 15,965 | 0 USD | 25.190 | 337,933.99 | 0.12 |
| US02043Q1076 | Alnylam Pharmaceuticals Inc Reg.Shares | SHS | 25,485 | 7,445 | 4,420 USD | 165.870 | 3,552,117.10 | 1.26 |
| US0231112063 | Amarin Corp. PLC Reg.Shs (Sp.ADRs) | SHS | 8 | 0 | 0 USD | 4.480 | 30.12 | 0.00 |
| US0311621009 | Amgen Inc. Reg.Shares | SHS | 57,010 | 13,565 | 24,680 USD | 242.460 | 11,615,179.70 | 4.13 |
| US03753U1060 | Apellis Pharmaceuticals Inc. Reg.Shares | SHS | 20,940 | 20,940 | 0 USD | 63.450 | 1,116,459.81 | 0.40 |
| US0396971071 | Ardelyx Inc. Reg.Shares | SHS | 23,015 | 73,310 | 197,635 USD | 7.830 | 151,428.47 | 0.05 |
| US0400476075 | Arena Pharmaceuticals Inc. Reg.Shares New | SHS | 37,625 | 0 | 0 USD | 69.930 | 2,210,929.16 | 0.79 |
| US04016X1019 | argenx SE Reg.Shares (Sp.ADRs) | SHS | 10,485 | 3,315 | 3,635 USD | 312.130 | 2,750,038.28 | 0.98 |
| US04280A1007 | Arrowhead Pharmaceuticals Inc. Reg.Shares | SHS | 12,445 | 0 | 26,760 USD | 81.500 | 852,289.82 | 0.30 |
| US04351P1012 | Ascendis Pharma A/S Nav.-Akt. (Spons.ADRs) | SHS | 13,695 | 3,310 | 16,885 USD | 134.270 | 1,545,168.40 | 0.55 |
| US05280R1005 | Autolus Therapeutics Ltd. Reg.Shs (Spons. ADRs) | SHS | 97,680 | 97,680 | 0 USD | 6.540 | 536,807.02 | 0.19 |
| US05455M1009 | Avrobio Inc. Reg.Shares | SHS | 38,735 | 38,735 | 0 USD | 8.980 | 292,290.49 | 0.10 |
| US07373V1052 | Beam Therapeutics Inc Reg.Shares | SHS | 3,085 | 3,085 | 16,080 USD | 110.790 | 287,204.03 | 0.10 |
| US07725L1026 | BeiGene Ltd. Reg.Shares (Sp.ADRs) | SHS | 6,805 | 10,320 | 3,515 USD | 357.080 | 2,041,871.69 | 0.73 |
| US09062X1037 | Biogen Inc. Reg.Shares | SHS | 40,000 | 0 | 3,360 USD | 345.720 | 11,620,352.09 | 4.13 |
| VGG111961055 | Biohaven Pharmac.Hldg Co.Ltd. Reg.Shares | SHS | 18,725 | 17,200 | 17,105 USD | 97.800 | 1,538,847.11 | 0.55 |
| US09061G1013 | Biomarin Pharmaceutical Inc. Reg.Shares | SHS | 39,445 | 0 | 17,760 USD | 83.460 | 2,766,337.30 | 0.98 |
| US09075V1026 | BioNTech SE Nam.-Akt. (sp.ADRs) | SHS | 29,135 | 13,035 | 2,370 USD | 228.060 | 5,583,402.46 | 1.99 |
| US09627Y1091 | Blueprint Medicines Corp. Reg.Shares | SHS | 25,785 | 0 | 0 USD | 87.580 | 1,897,609.60 | 0.67 |
| US10806X1028 | BridgeBio Pharma Inc. Reg.Shares | SHS | 33,228 | 23,528.25 | 13,860.25 USD | 60.120 | 1,678,641.54 | 0.60 |
| US16383L1061 | ChemoCentryx Inc. Reg.Shares | SHS | 18,065 | 0 | 4,545 USD | 14.090 | 213,886.69 | 0.08 |
| CH0334081137 | CRISPR Therapeutics AG Nam.-Aktien | SHS | 18,510 | 2,815 | 0 USD | 150.490 | 2,340,716.69 | 0.83 |
| US24344T1016 | Deciphera Pharmaceuticals Inc. Reg.Shares | SHS | 54,205 | 39,410 | 44,705 USD | 36.670 | 1,670,263.73 | 0.59 |
| US24823R1059 | Denali Therapeutics Inc. Reg.Shares | SHS | 19,155 | 0 | 8,405 USD | 76.880 | 1,237,457.59 | 0.44 |
| US2530311081 | Dicerna Pharmaceuticals Inc. Reg.Shares | SHS | 9,680 | 9,680 | 0 USD | 35.990 | 292,746.69 | 0.10 |
| US29428V1044 | Epizyme Inc. Reg.Shares | SHS | 31,985 | 0 | 130,375 USD | 8.560 | 230,067.31 | 0.08 |
| US29664W1053 | Esperion Therapeutic.Inc.(New) Reg.Shares | SHS | 15,205 | 0 | 14,640 USD | 21.130 | 269,973.24 | 0.10 |
| US31189P1021 | Fate Therapeutics Inc. Reg.Shares | SHS | 16,235 | 0 | 15,130 USD | 89.160 | 1,216,346.04 | 0.43 |
| US3755581036 | Gilead Sciences Inc. Reg.Shares | SHS | 355,210 | 24,480 | 73,460 USD | 67.930 | 20,275,967.65 | 7.21 |
| US40637H1095 | Halozyme Therapeutics Inc. Reg.Shares | SHS | 19,635 | 10,965 | 7,135 USD | 45.760 | 755,008.28 | 0.27 |
| IE00BQPVQZ61 | Horizon Therapeutics PLC Reg.Shares | SHS | 169,005 | 56,880 | 52,010 USD | 94.860 | 13,471,546.83 | 4.79 |
| US4495851085 | IGM Biosciences Inc. Reg.Shares | SHS | 11,825 | 11,825 | 0 USD | 83.540 | 830,100.00 | 0.30 |
| US45253H1014 | ImmunoGen Inc. Reg.Shares | SHS | 168,665 | 0 | 103,380 USD | 6.550 | 928,327.17 | 0.33 |
| US45337C1027 | Incyte Corp. Reg.Shares | SHS | 22,185 | 0 | 0 USD | 84.700 | 1,578,983.66 | 0.56 |
| US4576693075 | Insmed Inc. Reg.Shares | SHS | 19,225 | 7,930 | 0 USD | 29.370 | 474,465.99 | 0.17 |
| US45826J1051 | Intellia Therapeutics Inc. Reg.Shares | SHS | 21,450 | 5,045 | 18,800 USD | 151.610 | 2,732,687.28 | 0.97 |
| US4622221004 | Ionis Pharmaceuticals Inc. Reg.Shares | SHS | 19,710 | 0 | 7,260 USD | 39.550 | 655,040.12 | 0.23 |
| US4622601007 | Iovance Biotherapeutics Inc. Reg.Shares | SHS | 38,360 | 30,940 | 70,265 USD | 26.330 | 848,719.63 | 0.30 |
| US46333X1081 | Ironwood Pharmaceuticals Inc. Reg.Shares Cl.A | SHS | 41,720 | 0 | 10,945 USD | 12.720 | 445,929.50 | 0.16 |
| US48576A1007 | Karuna Therapeutics Inc Reg.Shares | SHS | 15,430 | 0 | 3,425 USD | 111.330 | 1,443,487.16 | 0.51 |
| US48576U1060 | Karyopharm Therapeutics Inc. Reg.Shares | SHS | 93,330 | 0 | 74,550 USD | 10.270 | 805,427.59 | 0.29 |
| US50015M1099 | Kodiak Sciences Inc. Reg.Shares | SHS | 13,580 | 6,960 | 15,130 USD | 90.890 | 1,037,171.72 | 0.37 |
| US5560991094 | MacroGenics Inc. Reg.Shares | SHS | 47,860 | 0 | 9,435 USD | 26.700 | 1,073,788.50 | 0.38 |
| US5588681057 | Madrigal Pharmaceuticals Inc. Reg.Shares | SHS | 7,350 | 7,350 | 0 USD | 97.200 | 600,327.72 | 0.21 |
| US59045L1061 | Mersana Therapeutics Inc. Reg.Shares | SHS | 134,180 | 9,190 | 0 USD | 13.280 | 1,497,340.78 | 0.53 |
| US60468T1051 | Mirati Therapeutics Inc. Reg.Shares | SHS | 16,870 | 0 | 0 USD | 162.370 | 2,301,736.82 | 0.82 |
| US60770K1079 | Moderna Inc. Reg.Shares | SHS | 119,680 | 17,310 | 8,255 USD | 234.460 | 23,578,986.43 | 8.39 |
| US6323071042 | Natera Inc. Reg.Shares | SHS | 12,400 | 21,850 | 22,315 USD | 116.380 | 1,212,648.21 | 0.43 |
| US64125C1099 | Neurocrine Biosciences Inc. Reg.Shares | SHS | 49,695 | 14,875 | 0 USD | 96.940 | 4,048,093.19 | 1.44 |
| US6700024010 | Novavax Inc. Reg.Shares | SHS | 28,225 | 10,620 | 0 USD | 208.940 | 4,955,532.54 | 1.76 |
| US74366E1029 | Protagonist Therapeutics Inc. Reg.Shares | SHS | 58,160 | 0 | 0 USD | 44.100 | 2,155,250.62 | 0.77 |
| US7504692077 | Radius Health Inc. Reg.Shares | SHS | 29,300 | 29,300 | 0 USD | 18.710 | 460,655.43 | 0.16 |
| US75886F1075 | Regeneron Pharmaceuticals Inc. Reg.Shares | SHS | 26,320 | 8,870 | 6,030 USD | 545.980 | 12,075,285.58 | 4.30 |
| US77313F1066 | Rocket Pharmaceuticals Inc. Reg.Shares | SHS | 32,920 | 5,610 | 31,230 USD | 43.330 | 1,198,624.93 | 0.43 |
| US78667J1088 | Sage Therapeutics Inc. Reg.Shares | SHS | 10 | 5,245 | 15,275 USD | 56.380 | 473.76 | 0.00 |
| US8036071004 | Sarepta Therapeutics Inc. Reg.Shares | SHS | 6,015 | 0 | 15,925 USD | 78.820 | 398,388.56 | 0.14 |
| US80706P1030 | Scholar Rock Holding Corp. Reg.Shares | SHS | 16,890 | 16,890 | 0 USD | 28.500 | 404,491.41 | 0.14 |

Investment portfolio at 30/06/2021
ISIN	Securities	Market	Shares/	Balance  Purchases  Redemptions	Price	Market value	% of net
Units/	30/06/2021	in EUR	assets
Currency	in the period under review
| US81181C1045 | Seagen Inc. Reg.Shares | SHS | 44,055 | 13,745 | 31,910 USD | 158.590 | 5,870,915.05 | 2.09 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| US81750R1023 | Seres Therapeutics Inc. Reg.Shares | SHS | 55,175 | 41,610 | 14,630 USD | 23.890 | 1,107,626.36 | 0.39 |
| US85205L1070 | SpringWorks Therapeutics Inc. Reg.Shares | SHS | 25,135 | 21,060 | 4,965 USD | 79.280 | 1,674,469.81 | 0.60 |
| US8693671021 | Sutro Biopharma Inc. Reg.Shares | SHS | 15,896 | 15,896 | 0 USD | 18.160 | 242,570.78 | 0.09 |
| US88322Q1085 | TG Therapeutics Inc. Reg.Shares | SHS | 105,435 | 26,125 | 0 USD | 37.610 | 3,332,137.60 | 1.19 |
| US89374L1044 | Translate Bio Inc. Reg.Shares | SHS | 19,260 | 0 | 64,315 USD | 25.660 | 415,286.42 | 0.15 |
| US90041T1088 | Turning Point Therap. Inc. Reg.Shares | SHS | 43,635 | 15,480 | 8,085 USD | 75.870 | 2,781,889.37 | 0.99 |
| US90184D1000 | Twist Bioscience Corp. Reg.Shares | SHS | 7,105 | 4,975 | 12,390 USD | 134.640 | 803,846.22 | 0.29 |
| US90400D1081 | Ultragenyx Pharmaceutical Inc. Reg.Shares | SHS | 10,240 | 5,165 | 0 USD | 96.290 | 828,544.68 | 0.29 |
| US91307C1027 | United Therapeutics Corp.(Del.) Reg.Shares | SHS | 21,110 | 19,295 | 2,835 USD | 177.000 | 3,139,758.83 | 1.12 |
| US92532F1003 | Vertex Pharmaceuticals Inc. Reg.Shares | SHS | 60,870 | 10,910 | 32,575 USD | 196.780 | 10,065,122.14 | 3.58 |
| US92764N1028 | Vir Biotechnology Inc. Reg.Shares | SHS | 23,995 | 43,735 | 19,740 USD | 46.560 | 938,790.13 | 0.33 |
| US9842411095 | Y-Mabs Therapeutics Inc. Reg.Shares | SHS | 28,735 | 0 | 0 USD | 33.880 | 818,067.98 | 0.29 |
| US98887Q1040 | Zai Lab Ltd.Reg.Shares (ADRs) | SHS | 13,920 | 1,975 | 0 USD | 177.870 | 2,080,543.17 | 0.74 |
| US98943L1070 | Zentalis Pharmaceuticals Inc. Reg.Shares | SHS | 14,205 | 4,705 | 10,455 USD | 53.190 | 634,901.01 | 0.23 |
| Biosciences: materials and services |  |  |  |  |  | 23,004,965.55 | 8.19 |
| US88025U1097	10X GENOMICS Inc. Reg.Shares | SHS | 6,915 | 9,220 | 19,525 USD | 201.330 | 1,169,864.25 | 0.42 |
| US05352A1007	Avantor Inc. Reg.Shares | SHS | 98,885 | 63,435 | 0 USD | 35.750 | 2,970,580.02 | 1.06 |
| IE0005711209	Icon PLC Reg.Shares | SHS | 9,395 | 9,395 | 0 USD | 214.040 | 1,689,765.81 | 0.60 |
| US4523271090	Illumina Inc. Reg.Shares | SHS | 24,310 | 7,305 | 8,820 USD | 479.180 | 9,788,551.57 | 3.48 |
| US87166B1026	Syneos Health Inc. Reg.Shares A | SHS | 98,135 | 98,135 | 0 USD | 89.570 | 7,386,203.90 | 2.63 |
| Retail: special |  |  |  |  |  | 794,565.02 | 0.28 |
| US71601V1052	Petco Health+Wellness Co.Inc. Reg.Shares Cl.A | SHS | 42,555 | 42,555 | 0 USD | 22.220 | 794,565.02 | 0.28 |
| Healthcare: equipment and products |  |  |  |  |  | 4,818,977.05 | 1.70 |
| US2521311074	DexCom Inc. Reg.Shares | SHS | 5,835 | 5,835 | 0 USD | 426.800 | 2,092,666.69 | 0.74 |
| VGG312491084	Establishment Labs Holdings In Reg.Shares | SHS | 15,220 | 15,220 | 0 USD | 86.640 | 1,108,071.76 | 0.39 |
| JE00BYSS4X48	Novocure Ltd. Reg.Shares | SHS | 6,620 | 2,435 | 2,235 USD | 223.870 | 1,245,342.13 | 0.44 |
| JE00BLG2ZQ72	Quotient Ltd. Reg.Shares | SHS | 113,495 | 0 | 0 USD | 3.910 | 372,896.47 | 0.13 |
| Healthcare: institutions and services |  |  |  |  |  | 2,803,745.14 | 1.00 |
| US40131M1099	Guardant Health Inc. Reg.Shares Cl.A | SHS | 26,110 | 9,900 | 16,110 USD | 127.790 | 2,803,745.14 | 1.00 |
| Internet and catalogue retail |  |  |  |  |  | 1,622,738.37 | 0.58 |
| US16679L1098	Chewy Inc. Reg.Shares | SHS | 23,585 | 7,255 | 4,565 USD | 81.880 | 1,622,738.37 | 0.58 |
| Pharmaceuticals |  |  |  |  |  | 30,762,315.57 | 10.95 |
| US00771V1089	Aerie Pharmaceuticals Inc. Reg.Shares | SHS | 108,825 | 0 | 16,355 USD | 16.230 | 1,484,164.32 | 0.53 |
| US04335A1051	Arvinas Inc. Reg.Shares | SHS | 21,500 | 0 | 0 USD | 76.210 | 1,376,845.51 | 0.49 |
| US0463531089	Astrazeneca PLC Reg.Shares (Spons.ADRs) | SHS | 240,590 | 104,395 | 0 USD | 60.180 | 12,166,468.80 | 4.33 |
| US05464T1043	Axsome Therapeutics Inc. Reg.Shares | SHS | 9,635 | 9,635 | 0 USD | 69.660 | 563,988.15 | 0.20 |
| US1101221083	Bristol-Myers Squibb Co. Reg.Shares | SHS | 82,695 | 27,195 | 50,180 USD | 66.270 | 4,605,014.62 | 1.64 |
| US1488061029	Catalent Inc. Reg.Shares | SHS | 15,110 | 10,630 | 15,420 USD | 109.150 | 1,385,871.60 | 0.49 |
| US5324571083	Eli Lilly and Company Reg.Shares | SHS | 10,545 | 44,545 | 34,000 USD | 229.370 | 2,032,441.20 | 0.72 |
| US46116X1019	Intra-Cellular Therapies Inc. Reg.Shares | SHS | 21,638 | 0 | 3,447 USD | 39.750 | 722,751.57 | 0.26 |
| US6402681083	Nektar Therapeutics Reg.Shares | SHS | 20,670 | 20,670 | 21,115 USD | 17.410 | 302,394.61 | 0.11 |
| US7170811035	Pfizer Inc. Reg.Shares | SHS | 152,445 | 152,445 | 0 USD | 39.100 | 5,008,696.69 | 1.78 |
| US75615P1030	Reata Pharmaceuticals Inc. Reg.Shares | SHS | 9,030 | 0 | 0 USD | 146.770 | 1,113,678.50 | 0.40 |
| Unlisted securities |  |  |  |  |  | 1,356.33 | 0.00 |
| Other securities |  |  |  |  |  | 1,356.33 | 0.00 |
| US284CVR0169	Elanco Animal Health Inc. |  |  |  |  |  |  |  |
| Anrechte (CVR Rights) | SHS | 64,110 | 64,110 | 0 USD | 0.025 | 1,356.33 | 0.00 |
| Total securities |  |  |  | EUR |  | 272,530,516.79 | 96.93 |
| Derivatives |  |  |  |  |  |  |  |
| (The positions marked with a minus sign have been sold) |  |  |  |  |  |  |  |
| Derivatives on individual securities |  |  |  |  |  |  |  |
| Warrants |  |  |  |  |  | 682,325.63 | 0.24 |
| Equity warrants |  |  |  |  |  | 682,325.63 | 0.24 |
| Advanced Inhalation WTS |  |  |  |  |  |  |  |
| (Foreign) 16/29/12/21 X | SHS | 333,334 | 0 | 0 USD | 2.436 | 682,325.63 | 0.24 |
| Total derivatives on individual securities | EUR |  | 682,325.63 | 0.24 |
| Bank deposits, money market instruments, money market funds and money market-related funds |  |  |  |  |
| Bank deposits |  |  |  |  |
| EUR deposits with custodial office |  |  |  |  |
| State Street Bank International GmbH	EUR	7,358,688.97 | % | 100.000 | 7,358,688.97 | 2.62 |
| Deposits in non-EU/EEA currencies |
| State Street Bank International GmbH | USD | 232,046.81 | % | 100.000 | 194,989.13 | 0.07 |
| Total bank deposits | EUR | 7,553,678.10 | 2.69 |
| Total of bank deposits, money market instruments, money market funds and money market-related funds  30) | EUR | 7,553,678.10 | 2.69 |

Investment portfolio at 30/06/2021
| ISIN | Securities | Market | Shares/ Units/ Currency | Balance Purchases Redemptions 30/06/2021 in the period under review |  | Price | Market value in EUR | % of net assets |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Other assets |  |  |  |  |  |  |  |  |
|  | Receivables from unit transactions |  | EUR | 99,320.72 |  |  | 99,320.72 | 0.04 |
|  | Receivables from securities transactions |  | EUR | 5,092,784.66 |  |  | 5,092,784.66 | 1.81 |
|  | Receivables from FX spots |  | EUR | 282,211.60 |  |  | 282,211.60 | 0.10 |
| Total other assets |  |  |  |  | EUR |  | 5,474,316.98 | 1.95 |
| Other payables |  |  |  |  |  |  |  |  |
|  | Liabilities from unit transactions |  | EUR | -65,144.43 |  |  | -65,144.43 | -0.02 |
|  | Liabilities from securities transactions |  | EUR | -4,299,259.61 |  |  | -4,299,259.61 | -1.53 |
|  | Liabilities from FX spots |  | EUR | -282,344.46 |  |  | -282,344.46 | -0.10 |
|  | Accruals |  | EUR | -452,495.66 |  |  | -452,495.66 | -0.16 |
| Total other payables |  |  |  |  | EUR |  | -5,099,244.16 | -1.81 |
| Fund assets |  |  |  |  | EUR |  | 281,141,593.34 | 100.00 |
|  | Total units in circulation of all unit classes |  |  |  | SHS |  | 1,278,281 |  |

30) 
Cash initial margins may be included in bank deposits.
Allianz Biotechnologie A (EUR)
| ISIN | DE0008481862 |
| --- | --- |
| Fund assets | 280,949,079.74 |
| Units in circulation | 1,277,079.327 |
| Unit value | 219.99 |

Allianz Biotechnologie R (EUR)
| ISIN | DE000A2AMPU5 |
| --- | --- |
| Fund assets | 192,513.60 |
| Units in circulation | 1,201.190 |
| Unit value | 160.27 |

Securities prices/market rates
Fund assets were valued on the basis of the following prices/market rates:
North and South American equities: prices as at 29/06/2021 or last known All other assets: prices/market rates as at 30/06/2021 or last known
Additional information on valuations
The valuation is conducted by the Custodian in cooperation with the Company.
Equities, subscription rights, exchange-traded funds (ETFs), participation certificates, bonds and exchange-traded derivatives are valued at their market price, provided that a market price is available.
Bonds for which no market price is available are valued at validated broker prices or with the help of regularly reviewed models and on the basis of relevant market information.
Participation certificates for which no market prices are available are valued at the mean of the bid-ask-spread.
Derivatives and subscription rights which are not traded on the market are valued with the help of regularly reviewed models and on the basis of relevant market information.
Investment fund units are valued at the redemption price published by the relevant investment company.
Bank deposits and other assets are valued at their nominal value, term deposits at their current value and liabilities at the repayment value.
Unlisted equities and shareholdings are valued at the current value, which is carefully determined with the help of suitable valuation models, taking account of the current market situation.
The methods used to value the Fund factor in the market effects resulting from the COVID-19 pandemic. No further adjustments were necessary at the time of preparation of the semi-annual report.
The investments reported in this semi-annual report, amounting to 97.17% of fund assets, are valued at stock market trading prices or market prices and 0.00% at imputed current market values and/or verified brokers’ quotations. The remaining 2.83% of fund assets consists of other assets, other liabilities and cash.
Exchange rate(s) and/or conversion factor(s) (indirect quotation) as at 30/06/2021
USA, Dollar	(USD)	1 Euro = USD	1.19005
Market key
Securities trading
X	=	Unlisted securities
Capital measures
All sales revenues resulting from capital measures (technical revenues) are reported as additions or disposals.
Voting
To the extent it was deemed to be in our investors’ interest, we either exercised ourselves or had our agents exercise, in accordance with our instructions, voting rights for equities held by the Fund.
Transactions carried out during the reporting period no longer listed in the investment portfolio
– purchases and redemptions of securities, fund units and borrower’s note loans (market allocations as per reporting date):
ISIN	Securities	Shares/	Purchases	Redemptions Units/
Currency
Exchange-traded securities Equities
| Biotechnology |  |
| --- | --- |
| CH0329023102 | AC Immune SA Namens-Aktien | SHS | 24,655 | 24,655 |
| US0042251084 | Acadia Pharmaceuticals Inc. Reg.Shares | SHS | 0 | 97,440 |
| US00773U1088 | Adverum Biotechnologies Inc. Reg.Shares | SHS | 0 | 127,470 |
| US0198181036 | Allovir Inc. Reg.Shares | SHS | 0 | 7,830 |
| US00166B1052 | ALX Oncology Holdings Inc. Reg.Shares | SHS | 0 | 2,960 |
| US03152W1099 | Amicus Therapeutics Inc. Reg.Shares | SHS | 22,925 | 51,325 |
| US0327241065 | Anaptysbio Inc. Reg.Shares | SHS | 27,155 | 27,155 |
| US03969T1097 | Arcturus Therapeutics Hlgs Inc Reg.Shares | SHS | 6,810 | 13,965 |
| CA05156V1022 | Aurinia Pharmaceuticals Inc. Reg.Shares | SHS | 24,225 | 115,000 |
| US09203E1055 | Black Diamond Therapeutics Reg.Shares | SHS | 0 | 25,880 |
| US28106W1036 | Editas Medicine Inc. Reg.Shares | SHS | 0 | 5,110 |
| US31572Q8087 | FibroGen Inc. Reg.Shares | SHS | 0 | 25,340 |
| US34633R1041 | Forma THERAPEUTICS INC. Reg.Shares | SHS | 29,655 | 29,655 |
| US35803L1089 | Frequency Therapeutics Inc. Reg.Shares | SHS | 22,880 | 22,880 |
| US3621LQ1099 | G1 Therapeutics Inc. Reg.Shares | SHS | 0 | 15,695 |
| US37890U1088 | Global Blood Therapeutics Inc. Reg.Shares | SHS | 0 | 3,675 |
| US4380831077 | Homology Medicines Inc. Reg.Shares | SHS | 0 | 16,945 |
| US45258J1025 | Immunovant Inc. Reg.Shares | SHS | 0 | 13,620 |
| US45773H2013 | Inovio Pharmaceuticals Inc. Reg.Shares | SHS | 0 | 34,920 |
| US53220K5048 | Ligand Pharmaceuticals Inc. Reg.Shares New | SHS | 2,505 | 2,505 |
| US75382E1091 | Rapt Therapeutics Inc. Reg.Shares | SHS | 0 | 17,970 |
| US75943R1023 | Relay Therapeutics Inc. Reg.Shares | SHS | 0 | 10,805 |
| US7602731025 | Repare Therapeutics Inc. Reg.Shares | SHS | 0 | 10,270 |
| US76029N1063 | Replimune Group Inc. Reg.Shares | SHS | 0 | 26,180 |
| US8006771062 | Sangamo Therapeutics Inc. Reg.Shares | SHS | 0 | 83,245 |
| US87808K1060 | TCR2 Therapeutics Inc. Reg.Shares | SHS | 24,575 | 24,575 |
| US89422G1076 | Travere Therapeutics Inc. Reg.Shares | SHS | 14,635 | 14,635 |
| US92337F1075 | Veracyte Inc. Reg.Shares | SHS | 0 | 12,075 |
| Biosciences: materials and services |
| US00650F1093 | Adaptive Biotechnologies Corp. Reg.Shares | SHS | 8,020 | 52,515 |
| US0843101017 | Berkeley Lights Inc. Reg.Shares | SHS | 9,150 | 9,150 |
| US56600D1072 | Maravai LifeSciences Hldgs Inc Reg.Shares Cl.A | SHS | 43,510 | 43,510 |
| US63009R1095 | NanoString Technologies Inc. Reg.Shares | SHS | 12,130 | 46,060 |
| US69404D1081 | Pacific Biosci.of California Reg.Shares | SHS | 0 | 53,190 |
| US71535D1063 | Personalis Inc. Reg.Shares | SHS | 10,675 | 21,375 |
| US69354M1080 | PRA Health Sciences Inc. Reg.Shares | SHS | 0 | 14,390 |
| KYG970081173 | WUXI Biologics (Cayman) Inc. Reg.Shares | SHS | 0 | 79,000 |
| Healthcare: equipment and products |
| CH0432492467 | Alcon AG Namens-Aktien | SHS | 0 | 23,575 |
| US05465P1012 | Axonics Inc. Reg.Shares | SHS | 16,070 | 16,070 |
| US08862L1035 | Beyond Air Inc. Reg.Shares | SHS | 227,389 | 227,389 |
| US2166484020 | Cooper Companies Inc. Reg.Shares | SHS | 0 | 2,805 |
| US64157F1030 | Nevro Corp. Reg.Shares | SHS | 0 | 13,895 |
| US82710M1009 | Silk Road Medical Inc. Reg.Shares | SHS | 0 | 25,930 |
| Healthcare: technology |
| US80810D1037 | Schrodinger Inc. Reg.Shares | SHS | 0 | 9,135 |
| Unlisted securities |  |  |  |  |
| Equities |  |  |  |  |
| Biotechnology |  |  |  |  |
| US28249H1041 | Eidos Therapeutics Inc. Reg.Shares | SHS | 5,645 | 5,645 |
| US33830X1046 | Five Prime Therapeutics Inc. Reg.Shares | SHS | 40,455 | 57,575 |
| Pharmaceuticals |  |  |  |  |
| US36197T1034 | GW Pharmaceuticals PLC Reg.Shs (Sp.ADRs) | SHS | 0 | 3,100 |

Derivatives
Warrants Securities warrants Equity warrants
Securities	Shares/	Volume
Units/	in ’000
Currency
(Option premiums and/or contract volumes pertaining to opening transactions; in the case of warrants, purchases and redemptions are indicated.)
XF0009937396	Advanced Inhalation WTS (Foreign) 18/01.02.21	SHS	0	227,389

Translation (ENDE, 2021-06-30):
# Inhalt
Allianz Biotechnologie
Entwicklung von Fondsvermögen und Anteilwert im
Struktur des Fondsvermögens in %
|  |  |  |  |
| --- | --- | --- | --- |
|  |  |  |  |
|  |  |  |  |
|  |  |  |  |
|  |  |  | 3,1  3,1 |

100
80
60
40
20
0
96,9 96,9
USD	Barreserve, Sonstiges
| Entwicklung von Fondsvermögen und Anteilwert im 3-Jahresvergleich |  |
| --- | --- |
|  | 30.06.2021 | 31.12.2020 | 31.12.2019 | 31.12.2018 |
| Fondsvermögen in Mio. EUR |  |  |  |  |
| - Anteilklasse A (EUR)	WKN: 848 186/ISIN: DE0008481862 | 280,9 | 267,9 | 296,0 | 201,8 |
| - Anteilklasse R (EUR)	WKN: A2A MPU/ISIN: DE000A2AMPU5 | 192.513,60  1) | 419.495,00  1) | 77.027,55  1) | 1.680,86  1) |
| Anteilwert in EUR |  |  |  |  |
| - Anteilklasse A (EUR)	WKN: 848 186/ISIN: DE0008481862 | 219,99 | 203,12 | 174,90 | 131,66 |
| - Anteilklasse R (EUR)	WKN: A2A MPU/ISIN: DE000A2AMPU5 | 160,27 | 147,35 | 125,76 | 93,85 |

1) 
Darstellungsweise nicht in Mio. EUR, aufgrund des geringen Fondsvermögens.
| Vermögensübersicht zum 30.06.2021 |  |
| --- | --- |
| Gliederung nach Anlagenart - Land | Kurswert in EUR | % des Fonds- vermögens  *) |  | Gliederung nach Anlagenart - Währung | Kurswert in EUR | % des Fonds- vermögens  *) |
| I. Vermögensgegenstände |  |  |  | I. Vermögensgegenstände |  |  |
| 1. Aktien | 272.529.160,46 | 96,93 |  | 1. Aktien | 272.529.160,46 | 96,93 |
| Deutschland | 5.583.402,46 | 1,99 |  | USD | 272.529.160,46 | 96,93 |
| Niederlande | 2.750.038,28 | 0,98 |  | 2. Sonstige Wertpapiere | 1.356,33 | 0,00 |
| Irland | 15.161.312,64 | 5,39 |  | USD | 1.356,33 | 0,00 |
| Dänemark | 1.545.168,40 | 0,55 |  | 3. Derivate | 682.325,63 | 0,24 |
| Schweiz | 2.757.894,96 | 0,98 |  | 4. Bankguthaben, Geldmarktpapiere, | 7.553.678,10 | 2,69 |
| Großbritannien | 14.321.544,54 | 5,09 |  | Geldmarkt- und geldmarktnahe Fonds |  |  |

| USA | 223.640.465,45 | 79,54 |
| --- | --- | --- |
| Kaiman-Inseln | 4.122.414,86 | 1,47 |
| Britische Jungfern-Inseln | 2.646.918,87 | 0,94 |
| 2. Sonstige Wertpapiere | 1.356,33 | 0,00 |
| USA | 1.356,33 | 0,00 |
| 3. Derivate | 682.325,63 | 0,24 |
| 4. Bankguthaben, Geldmarktpapiere, Geldmarkt- und geldmarktnahe Fonds | 7.553.678,10 | 2,69 |
| 5. Sonstige Vermögensgegenstände | 5.474.316,98 | 1,95 |
| II. Verbindlichkeiten | -5.099.244,16 | -1,81 |
| III. Fondsvermögen | 281.141.593,34 | 100,00 |

| 5. Sonstige Vermögensgegenstände | 5.474.316,98 | 1,95 |
| --- | --- | --- |
| II. Verbindlichkeiten | -5.099.244,16 | -1,81 |
| III. Fondsvermögen | 281.141.593,34 | 100,00 |

*) 
Durch Rundung der Prozentanteile bei der Berechnung können geringfügige Run- dungsdifferenzen entstanden sein.
Vermögensaufstellung zum 30.06.2021
| ISIN | Gattungsbezeichnung | Markt | Stück bzw. | Bestand | Käufe/	Verkäufe/ | Kurs | Kurswert | % des |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  | Anteile bzw. | 30.06.2021 | Zugänge	Abgänge |  | in EUR | Fondsver- |
| Währung	im Berichtszeitraum	mögens Börsengehandelte Wertpapiere	272.529.160,46	96,93 |
| Aktien |  |  |  |  |  |  | 272.529.160,46 | 96,93 |
| Biotechnologie |  |  |  |  |  |  | 208.721.853,76 | 74,23 |
| US00434H1086 | Acceleron Pharma Inc. Reg.Shares | STK | 8.740 | 0 | 0 USD | 124,490 | 914.283,10 | 0,33 |
| CH0499880968 | ADC Therapeutics S.A. Namens-Aktien Cl.C | STK | 20.515 | 0 | 28.775 USD | 24,200 | 417.178,27 | 0,15 |
| US00847X1046 | Agios Pharmaceuticals Inc. Reg.Shares | STK | 36.340 | 0 | 7.295 USD | 53,530 | 1.634.620,56 | 0,58 |
| US0144421072 | Alector Inc. Reg.Shares | STK | 500 | 0 | 0 USD | 20,620 | 8.663,50 | 0,00 |
| US0153511094 | Alexion Pharmaceuticals Inc. Reg.Shares | STK | 43.000 | 0 | 13.975 USD | 184,300 | 6.659.300,03 | 2,37 |
| US01671P1003 | Allakos Inc. Reg.Shares | STK | 30.485 | 0 | 0 USD | 88,320 | 2.262.455,53 | 0,80 |
| US0197701065 | Allogene Therapeutics Inc. Reg.Shares | STK | 15.965 | 15.965 | 0 USD | 25,190 | 337.933,99 | 0,12 |
| US02043Q1076 | Alnylam Pharmaceuticals Inc Reg.Shares | STK | 25.485 | 7.445 | 4.420 USD | 165,870 | 3.552.117,10 | 1,26 |
| US0231112063 | Amarin Corp. PLC Reg.Shs (Sp.ADRs) | STK | 8 | 0 | 0 USD | 4,480 | 30,12 | 0,00 |
| US0311621009 | Amgen Inc. Reg.Shares | STK | 57.010 | 13.565 | 24.680 USD | 242,460 | 11.615.179,70 | 4,13 |
| US03753U1060 | Apellis Pharmaceuticals Inc. Reg.Shares | STK | 20.940 | 20.940 | 0 USD | 63,450 | 1.116.459,81 | 0,40 |
| US0396971071 | Ardelyx Inc. Reg.Shares | STK | 23.015 | 73.310 | 197.635 USD | 7,830 | 151.428,47 | 0,05 |
| US0400476075 | Arena Pharmaceuticals Inc. Reg.Shares New | STK | 37.625 | 0 | 0 USD | 69,930 | 2.210.929,16 | 0,79 |
| US04016X1019 | argenx SE Reg.Shares (Sp.ADRs) | STK | 10.485 | 3.315 | 3.635 USD | 312,130 | 2.750.038,28 | 0,98 |
| US04280A1007 | Arrowhead Pharmaceuticals Inc. Reg.Shares | STK | 12.445 | 0 | 26.760 USD | 81,500 | 852.289,82 | 0,30 |
| US04351P1012 | Ascendis Pharma A/S Nav.-Akt. (Spons.ADRs) | STK | 13.695 | 3.310 | 16.885 USD | 134,270 | 1.545.168,40 | 0,55 |
| US05280R1005 | Autolus Therapeutics Ltd. Reg.Shs (Spons. ADRs) | STK | 97.680 | 97.680 | 0 USD | 6,540 | 536.807,02 | 0,19 |
| US05455M1009 | Avrobio Inc. Reg.Shares | STK | 38.735 | 38.735 | 0 USD | 8,980 | 292.290,49 | 0,10 |
| US07373V1052 | Beam Therapeutics Inc Reg.Shares | STK | 3.085 | 3.085 | 16.080 USD | 110,790 | 287.204,03 | 0,10 |
| US07725L1026 | BeiGene Ltd. Reg.Shares (Sp.ADRs) | STK | 6.805 | 10.320 | 3.515 USD | 357,080 | 2.041.871,69 | 0,73 |
| US09062X1037 | Biogen Inc. Reg.Shares | STK | 40.000 | 0 | 3.360 USD | 345,720 | 11.620.352,09 | 4,13 |
| VGG111961055 | Biohaven Pharmac.Hldg Co.Ltd. Reg.Shares | STK | 18.725 | 17.200 | 17.105 USD | 97,800 | 1.538.847,11 | 0,55 |
| US09061G1013 | Biomarin Pharmaceutical Inc. Reg.Shares | STK | 39.445 | 0 | 17.760 USD | 83,460 | 2.766.337,30 | 0,98 |
| US09075V1026 | BioNTech SE Nam.-Akt. (sp.ADRs) | STK | 29.135 | 13.035 | 2.370 USD | 228,060 | 5.583.402,46 | 1,99 |
| US09627Y1091 | Blueprint Medicines Corp. Reg.Shares | STK | 25.785 | 0 | 0 USD | 87,580 | 1.897.609,60 | 0,67 |
| US10806X1028 | BridgeBio Pharma Inc. Reg.Shares | STK | 33.228 | 23.528,25 | 13.860,25 USD | 60,120 | 1.678.641,54 | 0,60 |
| US16383L1061 | ChemoCentryx Inc. Reg.Shares | STK | 18.065 | 0 | 4.545 USD | 14,090 | 213.886,69 | 0,08 |
| CH0334081137 | CRISPR Therapeutics AG Nam.-Aktien | STK | 18.510 | 2.815 | 0 USD | 150,490 | 2.340.716,69 | 0,83 |
| US24344T1016 | Deciphera Pharmaceuticals Inc. Reg.Shares | STK | 54.205 | 39.410 | 44.705 USD | 36,670 | 1.670.263,73 | 0,59 |
| US24823R1059 | Denali Therapeutics Inc. Reg.Shares | STK | 19.155 | 0 | 8.405 USD | 76,880 | 1.237.457,59 | 0,44 |
| US2530311081 | Dicerna Pharmaceuticals Inc. Reg.Shares | STK | 9.680 | 9.680 | 0 USD | 35,990 | 292.746,69 | 0,10 |
| US29428V1044 | Epizyme Inc. Reg.Shares | STK | 31.985 | 0 | 130.375 USD | 8,560 | 230.067,31 | 0,08 |
| US29664W1053 | Esperion Therapeutic.Inc.(New) Reg.Shares | STK | 15.205 | 0 | 14.640 USD | 21,130 | 269.973,24 | 0,10 |
| US31189P1021 | Fate Therapeutics Inc. Reg.Shares | STK | 16.235 | 0 | 15.130 USD | 89,160 | 1.216.346,04 | 0,43 |
| US3755581036 | Gilead Sciences Inc. Reg.Shares | STK | 355.210 | 24.480 | 73.460 USD | 67,930 | 20.275.967,65 | 7,21 |
| US40637H1095 | Halozyme Therapeutics Inc. Reg.Shares | STK | 19.635 | 10.965 | 7.135 USD | 45,760 | 755.008,28 | 0,27 |
| IE00BQPVQZ61 | Horizon Therapeutics PLC Reg.Shares | STK | 169.005 | 56.880 | 52.010 USD | 94,860 | 13.471.546,83 | 4,79 |
| US4495851085 | IGM Biosciences Inc. Reg.Shares | STK | 11.825 | 11.825 | 0 USD | 83,540 | 830.100,00 | 0,30 |
| US45253H1014 | ImmunoGen Inc. Reg.Shares | STK | 168.665 | 0 | 103.380 USD | 6,550 | 928.327,17 | 0,33 |
| US45337C1027 | Incyte Corp. Reg.Shares | STK | 22.185 | 0 | 0 USD | 84,700 | 1.578.983,66 | 0,56 |
| US4576693075 | Insmed Inc. Reg.Shares | STK | 19.225 | 7.930 | 0 USD | 29,370 | 474.465,99 | 0,17 |
| US45826J1051 | Intellia Therapeutics Inc. Reg.Shares | STK | 21.450 | 5.045 | 18.800 USD | 151,610 | 2.732.687,28 | 0,97 |
| US4622221004 | Ionis Pharmaceuticals Inc. Reg.Shares | STK | 19.710 | 0 | 7.260 USD | 39,550 | 655.040,12 | 0,23 |
| US4622601007 | Iovance Biotherapeutics Inc. Reg.Shares | STK | 38.360 | 30.940 | 70.265 USD | 26,330 | 848.719,63 | 0,30 |
| US46333X1081 | Ironwood Pharmaceuticals Inc. Reg.Shares Cl.A | STK | 41.720 | 0 | 10.945 USD | 12,720 | 445.929,50 | 0,16 |
| US48576A1007 | Karuna Therapeutics Inc Reg.Shares | STK | 15.430 | 0 | 3.425 USD | 111,330 | 1.443.487,16 | 0,51 |
| US48576U1060 | Karyopharm Therapeutics Inc. Reg.Shares | STK | 93.330 | 0 | 74.550 USD | 10,270 | 805.427,59 | 0,29 |
| US50015M1099 | Kodiak Sciences Inc. Reg.Shares | STK | 13.580 | 6.960 | 15.130 USD | 90,890 | 1.037.171,72 | 0,37 |
| US5560991094 | MacroGenics Inc. Reg.Shares | STK | 47.860 | 0 | 9.435 USD | 26,700 | 1.073.788,50 | 0,38 |
| US5588681057 | Madrigal Pharmaceuticals Inc. Reg.Shares | STK | 7.350 | 7.350 | 0 USD | 97,200 | 600.327,72 | 0,21 |
| US59045L1061 | Mersana Therapeutics Inc. Reg.Shares | STK | 134.180 | 9.190 | 0 USD | 13,280 | 1.497.340,78 | 0,53 |
| US60468T1051 | Mirati Therapeutics Inc. Reg.Shares | STK | 16.870 | 0 | 0 USD | 162,370 | 2.301.736,82 | 0,82 |
| US60770K1079 | Moderna Inc. Reg.Shares | STK | 119.680 | 17.310 | 8.255 USD | 234,460 | 23.578.986,43 | 8,39 |
| US6323071042 | Natera Inc. Reg.Shares | STK | 12.400 | 21.850 | 22.315 USD | 116,380 | 1.212.648,21 | 0,43 |
| US64125C1099 | Neurocrine Biosciences Inc. Reg.Shares | STK | 49.695 | 14.875 | 0 USD | 96,940 | 4.048.093,19 | 1,44 |
| US6700024010 | Novavax Inc. Reg.Shares | STK | 28.225 | 10.620 | 0 USD | 208,940 | 4.955.532,54 | 1,76 |
| US74366E1029 | Protagonist Therapeutics Inc. Reg.Shares | STK | 58.160 | 0 | 0 USD | 44,100 | 2.155.250,62 | 0,77 |
| US7504692077 | Radius Health Inc. Reg.Shares | STK | 29.300 | 29.300 | 0 USD | 18,710 | 460.655,43 | 0,16 |
| US75886F1075 | Regeneron Pharmaceuticals Inc. Reg.Shares | STK | 26.320 | 8.870 | 6.030 USD | 545,980 | 12.075.285,58 | 4,30 |
| US77313F1066 | Rocket Pharmaceuticals Inc. Reg.Shares | STK | 32.920 | 5.610 | 31.230 USD | 43,330 | 1.198.624,93 | 0,43 |
| US78667J1088 | Sage Therapeutics Inc. Reg.Shares | STK | 10 | 5.245 | 15.275 USD | 56,380 | 473,76 | 0,00 |
| US8036071004 | Sarepta Therapeutics Inc. Reg.Shares | STK | 6.015 | 0 | 15.925 USD | 78,820 | 398.388,56 | 0,14 |
| US80706P1030 | Scholar Rock Holding Corp. Reg.Shares | STK | 16.890 | 16.890 | 0 USD | 28,500 | 404.491,41 | 0,14 |

Vermögensaufstellung zum 30.06.2021
| ISIN | Gattungsbezeichnung | Markt | Stück bzw. Anteile bzw. Währung | Bestand 30.06.2021 | Käufe/	Verkäufe/ Zugänge	Abgänge im Berichtszeitraum | Kurs | Kurswert in EUR | % des Fondsver- mögens |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| US81181C1045 | Seagen Inc. Reg.Shares | STK | 44.055 | 13.745 | 31.910 USD | 158,590 | 5.870.915,05 | 2,09 |
| US81750R1023 | Seres Therapeutics Inc. Reg.Shares | STK | 55.175 | 41.610 | 14.630 USD | 23,890 | 1.107.626,36 | 0,39 |
| US85205L1070 | SpringWorks Therapeutics Inc. Reg.Shares | STK | 25.135 | 21.060 | 4.965 USD | 79,280 | 1.674.469,81 | 0,60 |
| US8693671021 | Sutro Biopharma Inc. Reg.Shares | STK | 15.896 | 15.896 | 0 USD | 18,160 | 242.570,78 | 0,09 |
| US88322Q1085 | TG Therapeutics Inc. Reg.Shares | STK | 105.435 | 26.125 | 0 USD | 37,610 | 3.332.137,60 | 1,19 |
| US89374L1044 | Translate Bio Inc. Reg.Shares | STK | 19.260 | 0 | 64.315 USD | 25,660 | 415.286,42 | 0,15 |
| US90041T1088 | Turning Point Therap. Inc. Reg.Shares | STK | 43.635 | 15.480 | 8.085 USD | 75,870 | 2.781.889,37 | 0,99 |
| US90184D1000 | Twist Bioscience Corp. Reg.Shares | STK | 7.105 | 4.975 | 12.390 USD | 134,640 | 803.846,22 | 0,29 |
| US90400D1081 | Ultragenyx Pharmaceutical Inc. Reg.Shares | STK | 10.240 | 5.165 | 0 USD | 96,290 | 828.544,68 | 0,29 |
| US91307C1027 | United Therapeutics Corp.(Del.) Reg.Shares | STK | 21.110 | 19.295 | 2.835 USD | 177,000 | 3.139.758,83 | 1,12 |
| US92532F1003 | Vertex Pharmaceuticals Inc. Reg.Shares | STK | 60.870 | 10.910 | 32.575 USD | 196,780 | 10.065.122,14 | 3,58 |
| US92764N1028 | Vir Biotechnology Inc. Reg.Shares | STK | 23.995 | 43.735 | 19.740 USD | 46,560 | 938.790,13 | 0,33 |
| US9842411095 | Y-Mabs Therapeutics Inc. Reg.Shares | STK | 28.735 | 0 | 0 USD | 33,880 | 818.067,98 | 0,29 |
| US98887Q1040 | Zai Lab Ltd.Reg.Shares (ADRs) | STK | 13.920 | 1.975 | 0 USD | 177,870 | 2.080.543,17 | 0,74 |
| US98943L1070 | Zentalis Pharmaceuticals Inc. Reg.Shares | STK | 14.205 | 4.705 | 10.455 USD | 53,190 | 634.901,01 | 0,23 |
| Biowissenschaften Hilfsmittel & Dienstleistungen	23.004.965,55	8,19 |
| US88025U1097 | 10X GENOMICS Inc. Reg.Shares | STK | 6.915 | 9.220 | 19.525 USD | 201,330 | 1.169.864,25 | 0,42 |
| US05352A1007 | Avantor Inc. Reg.Shares | STK | 98.885 | 63.435 | 0 USD | 35,750 | 2.970.580,02 | 1,06 |
| IE0005711209 | Icon PLC Reg.Shares | STK | 9.395 | 9.395 | 0 USD | 214,040 | 1.689.765,81 | 0,60 |
| US4523271090 | Illumina Inc. Reg.Shares | STK | 24.310 | 7.305 | 8.820 USD | 479,180 | 9.788.551,57 | 3,48 |
| US87166B1026 | Syneos Health Inc. Reg.Shares A | STK | 98.135 | 98.135 | 0 USD | 89,570 | 7.386.203,90 | 2,63 |
| Einzelhandel: Spezial |  |  |  |  |  | 794.565,02 | 0,28 |
| US71601V1052	Petco Health+Wellness Co.Inc. Reg.Shares Cl.A | STK | 42.555 | 42.555 | 0 USD | 22,220 | 794.565,02 | 0,28 |
| Gesundheitswesen: Ausstattung & Produkte |  |  |  |  |  | 4.818.977,05 | 1,70 |
| US2521311074	DexCom Inc. Reg.Shares | STK | 5.835 | 5.835 | 0 USD | 426,800 | 2.092.666,69 | 0,74 |
| VGG312491084	Establishment Labs Holdings In Reg.Shares | STK | 15.220 | 15.220 | 0 USD | 86,640 | 1.108.071,76 | 0,39 |
| JE00BYSS4X48	Novocure Ltd. Reg.Shares | STK | 6.620 | 2.435 | 2.235 USD | 223,870 | 1.245.342,13 | 0,44 |
| JE00BLG2ZQ72	Quotient Ltd. Reg.Shares | STK | 113.495 | 0 | 0 USD | 3,910 | 372.896,47 | 0,13 |
| Gesundheitswesen: Einrichtungen & Dienste |  |  |  |  |  | 2.803.745,14 | 1,00 |
| US40131M1099	Guardant Health Inc. Reg.Shares Cl.A | STK | 26.110 | 9.900 | 16.110 USD | 127,790 | 2.803.745,14 | 1,00 |
| Internet Shopping & Katalogversand |  |  |  |  |  | 1.622.738,37 | 0,58 |
| US16679L1098	Chewy Inc. Reg.Shares | STK | 23.585 | 7.255 | 4.565 USD | 81,880 | 1.622.738,37 | 0,58 |
| Pharmazeutika |  |  |  |  |  | 30.762.315,57 | 10,95 |
| US00771V1089	Aerie Pharmaceuticals Inc. Reg.Shares | STK | 108.825 | 0 | 16.355 USD | 16,230 | 1.484.164,32 | 0,53 |
| US04335A1051	Arvinas Inc. Reg.Shares | STK | 21.500 | 0 | 0 USD | 76,210 | 1.376.845,51 | 0,49 |
| US0463531089	Astrazeneca PLC Reg.Shares (Spons.ADRs) | STK | 240.590 | 104.395 | 0 USD | 60,180 | 12.166.468,80 | 4,33 |
| US05464T1043	Axsome Therapeutics Inc. Reg.Shares | STK | 9.635 | 9.635 | 0 USD | 69,660 | 563.988,15 | 0,20 |
| US1101221083	Bristol-Myers Squibb Co. Reg.Shares | STK | 82.695 | 27.195 | 50.180 USD | 66,270 | 4.605.014,62 | 1,64 |
| US1488061029	Catalent Inc. Reg.Shares | STK | 15.110 | 10.630 | 15.420 USD | 109,150 | 1.385.871,60 | 0,49 |
| US5324571083	Eli Lilly and Company Reg.Shares | STK | 10.545 | 44.545 | 34.000 USD | 229,370 | 2.032.441,20 | 0,72 |
| US46116X1019	Intra-Cellular Therapies Inc. Reg.Shares | STK | 21.638 | 0 | 3.447 USD | 39,750 | 722.751,57 | 0,26 |
| US6402681083	Nektar Therapeutics Reg.Shares | STK | 20.670 | 20.670 | 21.115 USD | 17,410 | 302.394,61 | 0,11 |
| US7170811035	Pfizer Inc. Reg.Shares | STK | 152.445 | 152.445 | 0 USD | 39,100 | 5.008.696,69 | 1,78 |
| US75615P1030	Reata Pharmaceuticals Inc. Reg.Shares | STK | 9.030 | 0 | 0 USD | 146,770 | 1.113.678,50 | 0,40 |
| Nichtnotierte Wertpapiere |  |  |  |  |  | 1.356,33 | 0,00 |
| Andere Wertpapiere |  |  |  |  |  | 1.356,33 | 0,00 |
| US284CVR0169	Elanco Animal Health Inc. An- |  |  |  |  |  |  |  |
| rechte (CVR Rights) | STK | 64.110 | 64.110 | 0 USD | 0,025 | 1.356,33 | 0,00 |
| Summe Wertpapiervermögen |  |  |  | EUR |  | 272.530.516,79 | 96,93 |
| Derivate |  |  |  |  |  |  |  |
| (Bei den mit Minus gekennzeichneten Beständen handelt es sich um verkaufte Positionen) |
| Derivate auf einzelne Wertpapiere |  |  |  |  |  |  |  |
| Optionsscheine |  |  |  |  |  | 682.325,63 | 0,24 |
| Optionsscheine auf Aktien |  |  |  |  |  | 682.325,63 | 0,24 |
| Advanced Inhalation WTS (For- |  |  |  |  |  |  |  |
| eign) 16/29.12.21 X | STK | 333.334 | 0 | 0 USD | 2,436 | 682.325,63 | 0,24 |
| Summe Derivate auf einzelne Wertpapiere |  |  |  | EUR |  | 682.325,63 | 0,24 |
| Bankguthaben, Geldmarktpapiere, Geldmarkt- und geldmarktnahe Fonds |  |  |  |  |  |  |  |
| Bankguthaben |  |  |  |  |  |  |  |
| EUR-Guthaben bei der Verwahrstelle |  |  |  |  |  |  |  |
| State Street Bank International GmbH | EUR | 7.358.688,97 |  | % | 100,000 | 7.358.688,97 | 2,62 |
| Guthaben in Nicht-EU/EWR-Währungen |
| State Street Bank International GmbH | USD | 232.046,81 | % | 100,000 | 194.989,13 | 0,07 |

| Summe Bankguthaben | EUR | 7.553.678,10 | 2,69 |
| --- | --- | --- | --- |
| Summe der Bankguthaben, Geldmarktpapiere, Geldmarkt- und geldmarktnahe Fonds  30) | EUR | 7.553.678,10 | 2,69 |

Vermögensaufstellung zum 30.06.2021
| ISIN | Gattungsbezeichnung | Markt | Stück bzw. Anteile bzw. | Bestand 30.06.2021 | Käufe/	Verkäufe/ Zugänge	Abgänge | Kurs | Kurswert in EUR | % des Fondsver- |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  | Währung |  | im Berichtszeitraum |  |  | mögens |
| Sonstige Vermögensgegenstände |  |  |  |  |  |  |
| Forderungen aus Anteilscheingeschäften | EUR | 99.320,72 |  |  | 99.320,72 | 0,04 |
| Forderungen aus Wertpapiergeschäften | EUR | 5.092.784,66 |  |  | 5.092.784,66 | 1,81 |
| Forderungen aus Devisenspots | EUR | 282.211,60 |  |  | 282.211,60 | 0,10 |
| Summe Sonstige Vermögensgegenstände |  |  |  | EUR | 5.474.316,98 | 1,95 |
| Sonstige Verbindlichkeiten |  |  |  |  |  |  |
| Verbindlichkeiten aus Anteilscheingeschäften | EUR | -65.144,43 |  |  | -65.144,43 | -0,02 |
| Verbindlichkeiten aus Wertpapiergeschäften | EUR | -4.299.259,61 |  |  | -4.299.259,61 | -1,53 |
| Verbindlichkeiten aus Devisenspots | EUR | -282.344,46 |  |  | -282.344,46 | -0,10 |
| Kostenabgrenzung | EUR | -452.495,66 |  |  | -452.495,66 | -0,16 |
| Summe Sonstige Verbindlichkeiten |  |  |  | EUR | -5.099.244,16 | -1,81 |
| Fondsvermögen |  |  |  | EUR | 281.141.593,34 | 100,00 |
| Summe der umlaufenden Anteile aller Anteilklassen |  |  |  | STK | 1.278.281 |  |

30) 
Im Bankguthaben können Cash Initial Margin enthalten sein.
Allianz Biotechnologie A (EUR)
| ISIN | DE0008481862 |
| --- | --- |
| Fondsvermögen | 280.949.079,74 |
| Umlaufende Anteile | 1.277.079,327 |
| Anteilwert | 219,99 |

Allianz Biotechnologie R (EUR)
| ISIN | DE000A2AMPU5 |
| --- | --- |
| Fondsvermögen | 192.513,60 |
| Umlaufende Anteile | 1.201,190 |
| Anteilwert | 160,27 |

Wertpapierkurse bzw. Marktsätze
Die Vermögensgegenstände des Sondervermögens sind auf der Grundlage nachstehender Kurse/Marktsätze bewertet:
Aktien Nord- und Südamerika: Kurse per 29.06.2021 oder letztbekannte
Alle anderen Vermögenswerte: Kurse bzw. Marktsätze per 30.06.2021 oder letztbekannte
Ergänzende Anmerkung zur Bewertung
Die Bewertung erfolgt durch die Kapitalverwaltungsgesellschaft (KVG).
Aktien, Bezugsrechte, Börsennotierte Fonds (ETFs), Genussscheine, Rentenpapiere und börsengehandelte Derivate werden, sofern vorhanden, grundsätz- lich mit handelbaren Börsenkursen bewertet.
Rentenpapiere, für die keine handelbaren Börsenkurse vorliegen, werden mit validierten Kursstellungen von Brokern oder unter Einbeziehung der relevan- ten Marktinformationen im Rahmen von regelmäßig überprüften Modellen bewertet.
Genussscheine, für die keine handelbaren Börsenkurse vorliegen, werden mit dem Mittelwert von Bid- und Ask-Kurs bewertet.
Nicht börsengehandelte Derivate und Bezugsrechte werden unter Einbeziehung der relevanten Marktinformationen im Rahmen von regelmäßig über- prüften Modellen bewertet.
Investmentfondsanteile werden mit dem von der Investmentgesellschaft veröffentlichten Rücknahmepreis bewertet.
Bankguthaben und Sonstige Vermögensgegenstände werden zum Nennwert, Festgelder zum Verkehrswert und Verbindlichkeiten zum Rückzahlungsbe- trag bewertet.
Nicht notierte Aktien und Beteiligungen werden zu dem aktuellen Verkehrswert bewertet, der bei sorgfältiger Einschätzung nach geeigneten Bewertungs- modellen unter Berücksichtigung der aktuellen Marktgegebenheiten angemessen ist.
Die angewandten Verfahren zur Bewertung des Sondervermögens decken die aus der Covid-Pandemie herrührenden Marktauswirkungen ab. Darüber hi- nausgehende Anpassungen waren zum Zeitpunkt der Aufstellung des Halbjahresberichts nicht erforderlich.
Die in diesem Halbjahresbericht ausgewiesenen Anlagen werden i.H.v. 97,17% des Fondsvermögens mit handelbaren Börsenkursen oder Marktpreisen und 0,00% zu abgeleiteten Verkehrswerten bzw. validierten Kursstellungen von Brokern bewertet. Die verbleibenden 2,83% des Fondsvermögens bestehen aus Sonstigen Vermögensgegenständen, Sonstigen Verbindlichkeiten sowie Barvermögen.
Devisenkurs(e) bzw. Konversionsfaktor(en) (in Mengennotiz) per 30.06.2021
USA, Dollar	(USD)	1 Euro = USD	1,19005
Marktschlüssel
Wertpapierhandel
X	=	Nichtnotierte Wertpapiere
Kapitalmaßnahmen
Alle Umsätze, die aus Kapitalmaßnahmen hervorgehen (technische Umsätze), werden als Zu- oder Abgang ausgewiesen.
Stimmrechtsausübung
Stimmrechte aus den im Fonds enthaltenen Aktien haben wir, soweit es im Interesse unserer Anleger geboten erschien, entweder selbst wahrgenommen oder durch Beauftragte nach unseren Weisungen ausüben lassen.
Während des Berichtszeitraumes abgeschlossene Geschäfte, soweit sie nicht mehr in der Vermögensaufstellung erscheinen
- Käufe und Verkäufe in Wertpapieren, Investmentanteilen und Schuldscheindarlehen (Marktzuordnung zum Berichtsstichtag):
| ISIN | Gattungsbezeichnung | Stück bzw. | Käufe/ | Verkäufe/ |
| --- | --- | --- | --- | --- |
|  |  | Anteile bzw. Währung | Zugänge | Abgänge |

Börsengehandelte Wertpapiere Aktien
Biotechnologie
| CH0329023102 | AC Immune SA Namens-Aktien | STK | 24.655 | 24.655 |
| --- | --- | --- | --- | --- |
| US0042251084 | Acadia Pharmaceuticals Inc. Reg.Shares | STK | 0 | 97.440 |
| US00773U1088 | Adverum Biotechnologies Inc. Reg.Shares | STK | 0 | 127.470 |
| US0198181036 | Allovir Inc. Reg.Shares | STK | 0 | 7.830 |
| US00166B1052 | ALX Oncology Holdings Inc. Reg.Shares | STK | 0 | 2.960 |
| US03152W1099 | Amicus Therapeutics Inc. Reg.Shares | STK | 22.925 | 51.325 |
| US0327241065 | Anaptysbio Inc. Reg.Shares | STK | 27.155 | 27.155 |
| US03969T1097 | Arcturus Therapeutics Hlgs Inc Reg.Shares | STK | 6.810 | 13.965 |
| CA05156V1022 | Aurinia Pharmaceuticals Inc. Reg.Shares | STK | 24.225 | 115.000 |
| US09203E1055 | Black Diamond Therapeutics Reg.Shares | STK | 0 | 25.880 |
| US28106W1036 | Editas Medicine Inc. Reg.Shares | STK | 0 | 5.110 |
| US31572Q8087 | FibroGen Inc. Reg.Shares | STK | 0 | 25.340 |
| US34633R1041 | Forma THERAPEUTICS INC. Reg.Shares | STK | 29.655 | 29.655 |
| US35803L1089 | Frequency Therapeutics Inc. Reg.Shares | STK | 22.880 | 22.880 |
| US3621LQ1099 | G1 Therapeutics Inc. Reg.Shares | STK | 0 | 15.695 |
| US37890U1088 | Global Blood Therapeutics Inc. Reg.Shares | STK | 0 | 3.675 |
| US4380831077 | Homology Medicines Inc. Reg.Shares | STK | 0 | 16.945 |
| US45258J1025 | Immunovant Inc. Reg.Shares | STK | 0 | 13.620 |
| US45773H2013 | Inovio Pharmaceuticals Inc. Reg.Shares | STK | 0 | 34.920 |
| US53220K5048 | Ligand Pharmaceuticals Inc. Reg.Shares New | STK | 2.505 | 2.505 |
| US75382E1091 | Rapt Therapeutics Inc. Reg.Shares | STK | 0 | 17.970 |
| US75943R1023 | Relay Therapeutics Inc. Reg.Shares | STK | 0 | 10.805 |
| US7602731025 | Repare Therapeutics Inc. Reg.Shares | STK | 0 | 10.270 |
| US76029N1063 | Replimune Group Inc. Reg.Shares | STK | 0 | 26.180 |
| US8006771062 | Sangamo Therapeutics Inc. Reg.Shares | STK | 0 | 83.245 |
| US87808K1060 | TCR2 Therapeutics Inc. Reg.Shares | STK | 24.575 | 24.575 |
| US89422G1076 | Travere Therapeutics Inc. Reg.Shares | STK | 14.635 | 14.635 |
| US92337F1075 | Veracyte Inc. Reg.Shares | STK | 0 | 12.075 |
| Biowissenschaften Hilfsmittel & Dienstleistungen |
| US00650F1093 | Adaptive Biotechnologies Corp. Reg.Shares | STK | 8.020 | 52.515 |
| US0843101017 | Berkeley Lights Inc. Reg.Shares | STK | 9.150 | 9.150 |
| US56600D1072 | Maravai LifeSciences Hldgs Inc Reg.Shares Cl.A | STK | 43.510 | 43.510 |
| US63009R1095 | NanoString Technologies Inc. Reg.Shares | STK | 12.130 | 46.060 |
| US69404D1081 | Pacific Biosci.of California Reg.Shares | STK | 0 | 53.190 |
| US71535D1063 | Personalis Inc. Reg.Shares | STK | 10.675 | 21.375 |
| US69354M1080 | PRA Health Sciences Inc. Reg.Shares | STK | 0 | 14.390 |
| KYG970081173 | WUXI Biologics (Cayman) Inc. Reg.Shares | STK | 0 | 79.000 |
| Gesundheitswesen: Ausstattung & Produkte |
| CH0432492467 | Alcon AG Namens-Aktien | STK | 0 | 23.575 |
| US05465P1012 | Axonics Inc. Reg.Shares | STK | 16.070 | 16.070 |
| US08862L1035 | Beyond Air Inc. Reg.Shares | STK | 227.389 | 227.389 |
| US2166484020 | Cooper Companies Inc. Reg.Shares | STK | 0 | 2.805 |
| US64157F1030 | Nevro Corp. Reg.Shares | STK | 0 | 13.895 |
| US82710M1009 | Silk Road Medical Inc. Reg.Shares | STK | 0 | 25.930 |
| Gesundheitswesen: Technologie |
| US80810D1037 | Schrodinger Inc. Reg.Shares | STK | 0 | 9.135 |

Nichtnotierte Wertpapiere Aktien
Biotechnologie
| US28249H1041 | Eidos Therapeutics Inc. Reg.Shares | STK | 5.645 | 5.645 |
| --- | --- | --- | --- | --- |
| US33830X1046 | Five Prime Therapeutics Inc. Reg.Shares | STK | 40.455 | 57.575 |
| Pharmazeutika US36197T1034 | GW Pharmaceuticals PLC Reg.Shs (Sp.ADRs) | STK | 0 | 3.100 |

Derivate Optionsscheine
Gattungsbezeichnung	Stück bzw.	Volumen
Anteile bzw.	in 1.000
Währung
(In Opening-Transaktionen umgesetzte Optionsprämien bzw. Volumen der Optionsgeschäfte, bei Optionsscheinen Angabe der Käufe und Verkäufe.)
Wertpapier-Optionsscheine Optionsscheine auf Aktien
XF0009937396	Advanced Inhalation WTS (Foreign) 18/01.02.21	STK	0	227.389